About Metacrine
Metacrine is an emerging biotech company focused on developing best-in-class therapies to benefit patients with liver, gastrointestinal, and metabolic diseases. Metacrine’s lead program is focused on the Farnesoid X Receptor (FXR) and is based on a novel non-bile acid chemical scaffold. The lead molecule is expected to enter clinical development in early 2018.
LEARN MORE ABOUT METACRINEContact Us
Metacrine, Inc.
3985 Sorrento Valley Blvd.
Suite C
San Diego, CA 92121
P: (858) 369-7800
F: (858) 369-7801
Information
info@metacrine.com
Employment
careers@metacrine.com